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Abstract
Introduction: Primary cardiac lymphoma is rare.
Case Presentation: We report the case of a 64-year-old non-immunodeficient Caucasian man, with cardiac
tamponade and paroxysmal third-degree atrioventricular block. Echocardiography revealed the presence of a large
pericardial effusion with signs of tamponade and a right ventricular mass was suspected. Scanner investigations
clarified the sites, extension and anatomic details of myocardial and pericardial infiltration. Surgical resection was
performed due to the rapid impairment of his cardiac function. Analysis of the pericardial fluid and histology
confirmed the diagnosis of non-Hodgkin large B-cell lymphoma. He was treated with chemotherapy.
Conclusion: The prognosis remains poor for this type of tumor due to delays in diagnosis and the importance of
the site of disease.
Introduction
Primary cardiac tumors are rare. Cardiac lymphoma is
the rarest primary cardiac tumor and it is usually fatal.
The prognosis is poor because of diagnostic delay and
the importance of the site of disease. It often begins
with a pericardial effusion. Its treatment is based on
chemotherapy.
Case presentation
A 64-year-old immunocompetent Caucasian man with
no history of cardiac disease presented with chest pain,
dyspnea and edema of his lower limbs associated with a
degeneration of his general state. On physical examina-
tion he had a temperature of 37°C, blood pressure of
100/74 mmHg, and heart rate of 30 bpm. His jugular
venous pressure was high. The first and second heart
sounds were normal without any audible murmurs, rubs
or gallops. His chest was clear to auscultation. His
hemogram, hepatic enzymes and inflammation markers
were all normal. The patient was HIV-negative. His
chest X-ray revealed cardiomegaly as well as bilateral
pleural effusion. The standard 12-lead ECG indicated an
atrioventricular block of the third-degree. It returned to
normal spontaneously one hour later. Transthoracic
echocardiography (TTE) (Figures 1 and 2), demon-
strated not only a pericardial effusion of 23 mm by 35
mm with signs of tamponade but also the presence of a
large mass at the level of the right ventricle. The mass
had a wide base and was heterogeneous. It appeared
lobulated with a tissular echo texture that measured 5.5
cm by 5 cm. It was also attached to the tricuspid valve
creating a right ventricle inflow obstruction. The tumor
spread over the right atrium. He underwent an urgent
pericardial drainage which returned 600 cm3 of hemor-
rhagic liquid. Bacteriological and cytological analyses
revealed large cells suggestive of a lymphoproliferative
disorder. A computed tomography scan showed the pre-
sence of a right heart tumor on both sides of the tricus-
pid valve as well as peritoneal effusion. No other organ
involvement was observed (Figure 3). Coronary
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angiography accentuated an increase of a myocardial
blush in favor of the highly vascular nature of the tumor
(Figure 4). This examination was performed because the
patient was more than 40 years old. It was thought that
emergency surgery might be necessary at any time
because of size of his tumor.
Due to the rapid impairment of his cardiac function
and the life-threatening hemodynamic instability, an
echocardiography was performed which showed an
obstruction of the right ventricle inflow.
He underwent an emergency thoracotomy. The pur-
pose of this surgery was not to remove the entire
tumor. It was limited to freeing the tricuspid valve and
the intra-right ventricle obstruction. Surgical resection
of the mass was difficult and incomplete. The tumor
had infiltrated his right atrium, the atrioventricular sep-
tum and the proximal side of the right ventricle. Surgi-
cal removal was laborious but without complications.
The tumor was submitted to the pathology laboratory
as white and red soft fragments measuring 3 cm by 3
cm by 2 cm (Figures 5 and 6). Histological analysis
revealed non-Hodgkin large B-cell lymphoma (CD45+
CD20+ CD3- BCl2+ CD20- CD10- BCl6-). The
Figure 1 Transthoracic echocardiography four chamber view
showing a pericardial effusion and a large mass. The mass
measured 5.5 cm× 5 cm in the right ventricle and was attached to
the tricuspid valve creating a tricuspid stenosis. The tumor has
spread over the right atrium.
Figure 2 Continuous wave Doppler . The tumor created a
hemodynamic tricuspid stenosis which is a sign of high right
ventricle inflow velocities.
Figure 3 Coronary angiography showing an accentuation of
myocardial blush.
Figure 4 Computed tomography scan showing the presence of
a right heart tumor developing on both sides of the tricuspid
valve.
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lymphoma was classified as IE, according to the Ann
Arbor staging classification.
Chemotherapy with the R-CHOP (Rituximab,
Cytoxan, Hydroxydaunorubicin (Adriamycin), Oncovin
(Vincristine), Prednisone/Prednisolone) regimen began
immediately after resection.
After the first course of chemotherapy TTE demon-
strated a reduction in the size of the mass (Figure 7).
Discussion
Primary cardiac tumors are extremely rare in immuno-
competent persons. They are more frequent in patients
with acquired immunodeficiency syndrome (AIDS) or in
transplant recipients. This was not the case in our
patient. Approximately 25% of primary cardiac tumors
are malignant. Cardiac tumors are classified according
to their location and the degree of intra-cavitary
obstruction. It is interesting to separate primary cardiac
lymphoma in which cardiac events are the first indica-
tions, from secondary locations in which general events
are predominant and the discovery of the cardiac invol-
vement is often fortuitous [1].
Primary cardiac lymphoma is an extranodal non-
Hodgkin lymphoma exclusively located in the heart and/
or pericardium [2]. It represents 1.3% of primary cardiac
tumors (PCL) and less than 1% of all lymphomas [2-4].
The right atrium and right ventricle are the two most
frequently involved sites with two-thirds of cases invol-
ving the right atrium [2-5].
Clinical presentations associated with primary cardiac
lymphoma are heterogeneous. They are generally related
to the site of involvement in the heart which makes
early diagnosis difficult. In their series, Fuzellier et al.
reported right-sided heart failure, dyspnea, tamponade
and arrhythmias as the most frequent manifestations
[2]. Cardiac tamponade is a frequent mode of presenta-
tion. The association of a tamponade with an alteration
of the general state or the general signs leads directly to
a neoplasia disease [2-6]. Congestive heart failure is
explained by myocardial involvement. The disorders of
conduction are the consequence of the invasion of the
inter-atrial septum likely with an extension to the nodal
tissue. The mechanism of cardiac arrhythmia could be
the infiltration of the roof of the side wall of the right
atrium by the tumor tissue [7].
TTE visualizes the pericardial effusions easily. It also
allows an estimation of its tolerance and reveals the pre-
sence of any intracardiac mass. TEE is considered an initial
imaging method when an intra-cardiac mass is doubtful
[8,9]. ’It is better for identifying tumoral masses, allowing
suspicion for an infiltrated cardiac tumoral mass to be a
Figure 5 Macroscopic aspect of the tumor. The tumor is
infiltrating the right atrium, the atrioventricular septum and the
proximal side of the right ventricle.
Figure 6 Macroscopic aspect of the tumor which is infiltrating
the right atrium.
Figure 7 A transthoracic echocardiography four chamber view
showing a reduction of the size of the mass.
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primary cardiac lymphoma’ [6]. The sensitivity of TEE
for the detection of primary cardiac lymphoma
approaches 100% in some series in specialized units that
have experience with this kind of laboratory investigation
[5]. It is also a good follow-up examination allowing the
verification of the regression of the tumor after che-
motherapy in a few centers [5]. TEE is excellent at visua-
lizing tumors in the atria, but much less so for anterior
masses (for example, near the right ventricular apex),
where TTE is superior. In our department, we are
experienced in diagnosing cardiac tumors and monitor-
ing their regression by TTE. Computed tomography
allows the delineation of the cardiac mass and the speci-
fication of its connections with the cardiac structures as
well as the extent of the disease. An MRI becomes the
examination reference for the diagnosis of cardiac
tumors. It offers superior anatomic details of myocardial
and pericardial infiltration. This examination can also
serve as a reference for the follow-up of patients under-
going chemotherapy [2]. However, fast moving tumors
(such as some myxomas) will adversely affect the quality
of the MRI image. In our patient who had an auriculo-
ventricular block of the third degree in the electrocardio-
gram, echocardiography followed by computed
tomography can help in arriving at a hypothesis to
explain the origin of the conduction disorder. It is prob-
able that the tumor in this case report invaded the inter-
atrial septum and the atrioventricular node. We do not
have any explanation for why it was paroxysmal. It is
probable that the inflammation process around the
tumor is the cause. Cytological analysis of the pericardial
liquid does not always permit a diagnosis because the
effusion can be reactive [2]. The cytology results in the
pericardial fluid are often nonspecific. It demonstrates
atypical lymphoid cells [5]. Most cases require biopsy or
surgical excision for diagnosis [2]. In the presence of a
right-sided cardiac mass, an aggressive approach to
obtain a rapid histological diagnosis is important. Less
invasive procedures, such as TEE guided biopsy, endo-
myocardial transvenous biopsy, mediastinoscopy and
thoracoscopic pericardial window have been performed
with success [5].
The treatment of primary cardiac lymphoma is not
clearly codified. It differs according to the clinical team.
Surgical treatment is discouraging because surgical
resection of primary cardiac lymphoma is often difficult
and incomplete. It is reserved for patients with life-
threatening hemodynamic compromise caused by
mechanical complications (as was the case with our
patient) or tamponade [7]. Early systemic treatment
appears to be the only chance for cure.
Chemotherapy remains the preferred initial treatment.
It should be guided by the immunohistological charac-
teristics of the lymphoma and its extension to other
organs. At the end of the treatment, we can expect a
reduction of any rhythm disorders due to regression of
the tumor mass [6].
Conclusion
Primary cardiac lymphoma is rare. The presence of a
right cardiac mass raises the possibility of primary car-
diac lymphoma. Echocardiography is the preferred pro-
cedure for diagnosis and follow-up. In addition, it allows
an estimation of the hemodynamic state. Rapid histolo-
gical diagnosis is important because systemic therapy
can influence the prognosis in the presence of a primary
cardiac lymphoma [2].
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